By
AmyT on
December 13, 2010
Today Medtronic announces what is sure to be the first of a whole new generation of diabetes management software: its CareLink® Pro 3.0 Therapy Management Software — the first system to include algorithms capable of analyzing data from a patient’s insulin pump, continuous glucose monitoring (CGM) device, and blood glucose meter “to identify the most important patient information in one easy-to-use dashboard.”
Take note that this first 3.0 version is for clinicians only, but similar programs…
Read more »
By
AmyT on
November 22, 2010
Two weeks ago, the Transportation Security Administration announced they’d be implementing new “aggressive” screening methods, including full-body scans using advanced imaging technology and more invasive “pat-downs” for passengers who either set off the traditional alarm or cannot simply walk through the scanners for any reason. Almost immediately, there was an outcry across the country over invasion of privacy, and stories began flooding the media.
For PWDs, this set off a flurry of conversation about how…
Read more »
By
AmyT on
August 24, 2010
I could call today’s guest post a “straggler” from my Summer Reading series, but that might downplay its impact. Good things take time, as noted today by Samantha Katz, who along with a fellow graduate student at Northwestern University, won the the $10K Grand Prize in the 2009 DiabetesMine Design Challenge.
She was subsequently hired by Medtronic as a Global Product Manager for their evolving insulin pump systems (! – and she served as a…
Read more »
{Note: this is second in a two-part series aimed not only at patients, but those in the Pharma industry as well.}
I was interviewed the other day for an upcoming story about Sanofi-Aventis’ new strategy to not just offer individual diabetes products, but become a “full diabetes management vendor.” They are not alone. Medtronic, Roche, Bayer, Abbott and others are among the big industry players talking about more of a “systems approach” to diabetes as…
Read more »
{Note: this two-part series is aimed as much at Pharma as at patients. If you work in the industry, please read.}
If the emphasis among diabetes systems vendors last year at the annual American Diabetes Association Conference was “data visualization,” then this year’s was “data interpretation.“ I am 100% more enthused about the latter, and I’ll tell you why.
It seemed that last year, all the big players — J&J, Medtronic, Abbott Diabetes, Roche, and…
Read more »
